Ontology highlight
ABSTRACT:
SUBMITTER: Lolli G
PROVIDER: S-EPMC7340218 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
Lolli Ginevra G Casadei Beatrice B Argnani Lisa L Nanni Laura L Cavo Michele M Zinzani Pier Luigi PL
Mediterranean journal of hematology and infectious diseases 20200701 1
<h4>Background</h4>Sézary syndrome (SS) is a rare lymphoproliferative neoplasm, almost incurable outside the setting of allogeneic transplantable patients. The prognosis for relapsed/refractory patients remains poor, as the available drugs confer short-lasting remission. In this setting, the anti-chemokine receptor type 4 (CCR4) monoclonal antibody mogamulizumab demonstrated efficacy in an international, open-label, randomized controlled phase 3 trial (MAVORIC) versus vorinostat.<h4>Case descrip ...[more]